A citation-based method for searching scientific literature

Kirsty E Stuart, Nehmat Houssami, Richard Taylor, Andrew Hayen, John Boyages. BMC Cancer 2015
Times Cited: 45







List of co-cited articles
263 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
432
44

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
307
42

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.
Jack Cuzick, Ivana Sestak, Sarah E Pinder, Ian O Ellis, Sharon Forsyth, Nigel J Bundred, John F Forbes, Hugh Bishop, Ian S Fentiman, William D George. Lancet Oncol 2011
308
42

Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
Mila Donker, Saskia Litière, Gustavo Werutsky, Jean-Pierre Julien, Ian S Fentiman, Roberto Agresti, Philippe Rouanet, Christine Tunon de Lara, Harry Bartelink, Nicole Duez,[...]. J Clin Oncol 2013
197
37

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.
Fredrik Wärnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson,[...]. J Clin Oncol 2014
105
37

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
369
35

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
Beryl McCormick, Kathryn Winter, Clifford Hudis, Henry Mark Kuerer, Eileen Rakovitch, Barbara L Smith, Nour Sneige, Jennifer Moughan, Amit Shah, Isabelle Germain,[...]. J Clin Oncol 2015
216
26

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Lawrence J Solin, Robert Gray, Lorie L Hughes, William C Wood, Mary Ann Lowen, Sunil S Badve, Frederick L Baehner, James N Ingle, Edith A Perez, Abram Recht,[...]. J Clin Oncol 2015
147
26

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
306
24

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
188
24


A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Frederick L Baehner, Refik Saskin, Steven M Butler, Alan Tuck, Sandip Sengupta, Leela Elavathil, Prashant A Jani,[...]. Breast Cancer Res Treat 2015
132
22

Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Min Yi, Funda Meric-Bernstam, Henry M Kuerer, Elizabeth A Mittendorf, Isabelle Bedrosian, Anthony Lucci, Rosa F Hwang, Jaime R Crow, Sheng Luo, Kelly K Hunt. J Clin Oncol 2012
86
22

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
172
22

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
198
22

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.
M Luke Marinovich, Lamiae Azizi, Petra Macaskill, Les Irwig, Monica Morrow, Lawrence J Solin, Nehmat Houssami. Ann Surg Oncol 2016
79
22

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Mathias Worni, Igor Akushevich, Rachel Greenup, Deba Sarma, Marc D Ryser, Evan R Myers, E Shelley Hwang. J Natl Cancer Inst 2015
104
20

Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
Laura C Collins, Ninah Achacoso, Reina Haque, Larissa Nekhlyudov, Charles P Quesenberry, Stuart J Schnitt, Laurel A Habel, Suzanne W Fletcher. Ann Surg Oncol 2015
20
45

Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
Caroline Sweldens, Stephanie Peeters, Erik van Limbergen, Hilde Janssen, Annouschka Laenen, Sujata Patil, Kimberly J Van Zee, Caroline Weltens. Cancer J 2014
32
28

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
181
20

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Richard G Margolese, Reena S Cecchini, Thomas B Julian, Patricia A Ganz, Joseph P Costantino, Laura A Vallow, Kathy S Albain, Patrick W Whitworth, Mary E Cianfrocca, Adam M Brufsky,[...]. Lancet 2016
89
17

The natural history of ductal carcinoma in situ of the breast: a review.
Bircan Erbas, Elena Provenzano, Jane Armes, Dorota Gertig. Breast Cancer Res Treat 2006
202
17

Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
F Wang, H Li, P H Tan, E T Chua, R M C Yeo, F L W T Lim, S W Kim, D Y H Tan, F Y Wong. Clin Oncol (R Coll Radiol) 2014
24
33

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
Bernard Fisher, Stewart Anderson, John Bryant, Richard G Margolese, Melvin Deutsch, Edwin R Fisher, Jong-Hyeon Jeong, Norman Wolmark. N Engl J Med 2002
15

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
John F Forbes, Ivana Sestak, Anthony Howell, Bernardo Bonanni, Nigel Bundred, Christelle Levy, Gunter von Minckwitz, Wolfgang Eiermann, Patrick Neven, Michael Stierer,[...]. Lancet 2016
86
15

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.
E Rakovitch, S Nofech-Mozes, W Hanna, S Narod, D Thiruchelvam, R Saskin, J Spayne, C Taylor, L Paszat. Br J Cancer 2012
86
15

Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
Elizabeth Fitzsullivan, Sara A Lari, Benjamin Smith, Abigail S Caudle, Savitri Krishnamurthy, Anthony Lucci, Elizabeth A Mittendorf, Gildy V Babiera, Dalliah M Black, Jamie L Wagner,[...]. Ann Surg Oncol 2013
28
25

Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
Yasuaki Sagara, Rachel A Freedman, Ines Vaz-Luis, Melissa Anne Mallory, Stephanie M Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. J Clin Oncol 2016
80
13

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS).
Julia S Wong, Yu-Hui Chen, Michele A Gadd, Rebecca Gelman, Susan C Lester, Stuart J Schnitt, Dennis C Sgroi, Barbara J Silver, Barbara L Smith, Susan L Troyan,[...]. Breast Cancer Res Treat 2014
68
13

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
47
13

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
166
13

Impact of Age on Risk of Recurrence of Ductal Carcinoma In Situ: Outcomes of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
Patricia A Cronin, Cristina Olcese, Sujata Patil, Monica Morrow, Kimberly J Van Zee. Ann Surg Oncol 2016
24
25

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.
Yasuaki Sagara, Melissa Anne Mallory, Stephanie Wong, Fatih Aydogan, Stephen DeSantis, William T Barry, Mehra Golshan. JAMA Surg 2015
101
13


Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
96
13


Molecular phenotypes of DCIS predict overall and invasive recurrence.
K E Williams, N L P Barnes, A Cramer, R Johnson, K Cheema, J Morris, M Howe, N J Bundred. Ann Oncol 2015
63
13

Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ.
Monica Morrow, Kimberly J Van Zee, Lawrence J Solin, Nehmat Houssami, Mariana Chavez-MacGregor, Jay R Harris, Janet Horton, Shelley Hwang, Peggy L Johnson, M Luke Marinovich,[...]. J Clin Oncol 2016
114
13

Outcomes in patients treated with mastectomy for ductal carcinoma in situ.
Dawn Owen, Scott Tyldesley, Cheryl Alexander, Caroline Speers, Pauline Truong, Alan Nichol, Elaine S Wai. Int J Radiat Oncol Biol Phys 2013
29
20

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.
Umberto Veronesi, Natale Cascinelli, Luigi Mariani, Marco Greco, Roberto Saccozzi, Alberto Luini, Marisel Aguilar, Ettore Marubini. N Engl J Med 2002
11


Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
J P Julien, N Bijker, I S Fentiman, J L Peterse, V Delledonne, P Rouanet, A Avril, R Sylvester, F Mignolet, H Bartelink,[...]. Lancet 2000
399
11



Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
184
11

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
364
11

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
230
11

Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis.
Xining Zhang, Hongji Dai, Ben Liu, Fengju Song, Kexin Chen. Eur J Cancer Prev 2016
24
20

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
G Curigliano, D Disalvatore, A Esposito, G Pruneri, M Lazzeroni, A Guerrieri-Gonzaga, A Luini, R Orecchia, A Goldhirsch, N Rotmensz,[...]. Ann Oncol 2015
33
15

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
Lotte E Elshof, Marjanka K Schmidt, Emiel J Th Rutgers, Flora E van Leeuwen, Jelle Wesseling, Michael Schaapveld. Ann Surg 2018
30
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.